3 insiders bought €30k of shares over the last 90 days, the latest filed 17 Sept 2026.
Beneficient is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 18 October 2026, 13 filings were filed, from 6 insiders.
Only purchases show up on the open market, 3 purchases in all worth €30k, filed by 3 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive and 1 chief executive. Cangany Peter T Jr filed the largest purchase, €17k, on 17 September 2026.
With 13 filings in twelve months, the company is quieter than the median of 19 filings across the 5,808 companies we follow on the same exchange. Looking back to 2023, when coverage begins, insiders filed 8 purchases and 27 sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 March 2026), the company reported net income of -87.4 m USD.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. Purchases made close together by different insiders form what is called a cluster. The latest purchase dates back some time: it was published 31 days ago, on 17 September 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended March 2026 · cache
25 of 71 declarations
Beneficient is a company listed on the XNAS market, specializing in financial solutions for investors. It provides services that facilitate access to alternative assets.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Mar 2026 | n.d. | -87.4 m USD | n.d. | 10-K |
| Mar 2025 | n.d. | 51.2 m USD | n.d. | 10-K |
| Mar 2024 | n.d. | -2.10 bn USD | n.d. | 10-K |
| Mar 2023 | n.d. | -131.0 m USD | -1.94 USD | 10-K |
| Dec 2021 | 55.3 m USD | -63.0 m USD | -1.84 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.